Clinical Trials Browser

Phase 1 × Interleukin-18 × Other solid neoplasm × Clear all

NCT00085878 2008-10-16

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer